Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"The Lancet. Oncology"
NOT collection:"EPA"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22The+Lancet.+Oncology%22&filter%5B%5D=NOT+collection%3AEPA&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22The+Lancet.+Oncology%22&filter%5B%5D=NOT+collection%3AEPA&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22The+Lancet.+Oncology%22&filter%5B%5D=NOT+collection%3AEPA&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
PubPharm (588)
1
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412) : a randomised, double-blind, phase 3 trial
enthalten in:
The Lancet. Oncology
| 2024
von
Machiels, J.
|
Tao, Y.
|
Licitra, L.
| +125
Wird geladen...
2
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02) : patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trial
enthalten in:
The Lancet. Oncology
| 2024
von
Fehm, T.
|
Cottone, F.
|
Dunton, K.
| +13
Wird geladen...
3
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1) : patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
enthalten in:
The Lancet. Oncology
| 2024
von
Burris, H.
|
Okusaka, T.
|
Vogel, A.
| +14
Wird geladen...
4
68Ga-RM2 PET-MRI versus MRI alone for evaluation of patients with biochemical recurrence of prostate cancer : a single-centre, single-arm, phase 2/3 imaging trial
enthalten in:
The Lancet. Oncology
| 2024
von
Duan, H.
|
Moradi, F.
|
Davidzon, G.
| +8
Wird geladen...
5
Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia : analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial
enthalten in:
The Lancet. Oncology
| 2024
von
Kater, A.
|
Arslan, .
|
Demirkan, F.
| +24
Wird geladen...
6
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER) : survival endpoints at 5 years in an open-label, randomised, phase 3 study
enthalten in:
The Lancet. Oncology
| 2024
von
Pfister, C.
|
Gravis, G.
|
Flechon, A.
| +53
Wird geladen...
7
Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours : a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trial
enthalten in:
The Lancet. Oncology
| 2024
von
Bajpai, J.
|
Kapu, V.
|
Rath, S.
| +16
Wird geladen...
8
Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585) : an interim analysis of the multicentre, double-blind, randomised phase 3 study
enthalten in:
The Lancet. Oncology
| 2024
von
Shitara, K.
|
Rha, S.
|
Wyrwicz, L.
| +22
Wird geladen...
9
Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130) : final overall survival analysis results from a randomised, controlled, phase 3 study
enthalten in:
The Lancet. Oncology
| 2024
von
Grande, E.
|
Arranz, J.
|
De Santis, M.
| +20
Wird geladen...
10
Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130) : final overall survival analysis from a randomised, controlled, phase 3 study
enthalten in:
The Lancet. Oncology
| 2024
von
Bamias, A.
|
Davis, I.
|
Galsky, M.
| +21
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[59]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Filter aufheben
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: The Lancet. Oncology
Medienart
588
Aufsätze
577
E-Artikel
577
E-Ressourcen
11
Gedruckte Aufsätze
Zeitschriftentitel
The Lancet. Oncology
Thema
588
Clinical Trial, Phase III
576
Journal Article
562
Randomized Controlled Trial
470
Research Support, Non-U.S. Gov't
426
Multicenter Study
223
Comparative Study
105
Antibodies, Monoclonal, Humanized
90
EC 2.7.10.1
80
Antineoplastic Agents
67
Cisplatin
67
Q20Q21Q62J
61
Fluorouracil
61
U3P01618RT
59
Receptor, ErbB-2
51
Taxoids
48
15H5577CQD
48
Docetaxel
46
P88XT4IS4D
46
Paclitaxel
44
Protein Kinase Inhibitors
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
156
2020-
409
2010-2019
23
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
588
Englisch
Haven't found what you're looking for?
Wird geladen...